MS
Mudit Saxena
About Mudit Saxena
Data last updated:
Mudit Saxena is a Designated Partner at Ambroxir Pharmaceuticals Llp (since 2025) and Director at Ambroxir Consultancy Private Limited (since 2024). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ambroxir Pharmaceuticals Llp ACM-3009 | Designated Partner | 24 Feb 2025 | 2025 | Active | |
| Ambroxir Consultancy Private Limited U58200MP2024PTC072570 | Director | 13 Aug 2024 | 2024 | Active |
Board colleagues of Mudit Saxena
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rachana Saxena | 10742302 | Ambroxir Pharmaceuticals Llp , Ambroxir Consultancy Private Limited | Designated Partner |
| Shruti Saxena | 11387807 | Ambroxir Consultancy Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mudit Saxena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mudit Saxena
Mudit Saxena currently holds 2 directorships: Ambroxir Pharmaceuticals Llp (Designated Partner, since 24 Feb 2025); Ambroxir Consultancy Private Limited (Director, since 13 Aug 2024).
Mudit Saxena was first appointed on 13 Aug 2024 as Director at Ambroxir Consultancy Private Limited. The most recent appointment on record is 24 Feb 2025 at Ambroxir Pharmaceuticals Llp.
The current boards of Mudit Saxena's companies include Rachana Saxena (Ambroxir Pharmaceuticals Llp), Shruti Saxena (Ambroxir Consultancy Private Limited).